Lysergic acid diethylamide, abbreviated LSD is semisynthetic psychedelic drug that we use in religious or healing purposes for thousands of years. It was first synthesised by Albert Hofmann in 1938 from ergotamine, a chemical derived by Arthur Stoll from ergot, a grain fungus that typically grows on rye. LSD is typically delivered orally, usually on […]
scientific research and pioneering research on lsd
Since 1998, the Beckley Foundation has collaborated with leading international institutions to produce evidence-based research around LSD and neurological activity. As a personal friend of Albert Hoffman (the inventor of LSD), Beckley Foundation Director Amanda Feilding has always had a passion for scientific discovery involving LSD and has published numerous reports on the drug.
In 2013, the Beckley Foundation, in collaboration with Imperial College London, will become the first organisation ever to use modern brain-imaging technology (fMRI and MEG) during an LSD experience. Alongside the neuro-imaging, we shall measure the effects of the drug on perception and on the functions of self-reflection and auto-biographical memory recollection. We expect that this research will elucidate the mechanisms that underlie changing state of consciousness, highlighting new avenues for potential medical and therapeutic treatment.